Is Psoriatic Arthritis Hereditary? Risks, Testing, Diagnosis
Healthline· 4 days agoPsoriatic arthritis (PsA) is a type of arthritis that affects some people with psoriasis, an...
UCB Announces First Detailed Data from Two Phase 3 Bimekizumab Studies in Psoriatic Arthritis to be...
19 Action News Cleveland· 5 days agoFirst presentations from the BE OPTIMAL and BE COMPLETE studies evaluating bimekizumab in the treatment of adults with active psoriatic arthritis who were ...
Psoriatic arthritis support group: How to find the right one
Medical News Today· 5 days agoPsoriatic arthritis (PsA) support groups can help a person living with PsA feel understood. Support...
Apremilast for athletes: Side effects, risks, and safety
Medical News Today· 4 days agoPsoriatic arthritis (PsA) can cause swollen and tender joints. It often affects people with...
The Best Habits To Follow When Dealing With Arthritis, Expert Says — Eat This Not That
Eat This, Not That!· 5 days agoArthritis is a common, painful disorder many people live with on the regular. In fact, 58.5 million...
What I Wish Everyone Knew About Psoriatic Arthritis and Psoriasis
WebMD· 2 days agoImportant: The opinions expressed in WebMD Blogs are solely those of the User, who may or may not...
AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple Inflammatory...
News 12 Augusta· 4 days ago- SELECT-AXIS 2 highlights the efficacy and safety data of upadacitinib (RINVOQ®) in patients with non-radiographic axial spondyloarthritis, and in patients with radiographic axial spondyloarthritis ...
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA
Zacks via Yahoo Finance· 5 days agoCHMP recommended the approval of the drug used alone or in combination with methotrexate, in the...
AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate
Zacks via Yahoo Finance· 5 days agoRinvoq is already approved in the EU for four indications — rheumatoid arthritis, active psoriatic ...
The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib...
Morningstar· 1 day agoNORTH CHICAGO, Ill., May 27, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced The Lancet published results from three pivotal Phase 3 clinical trials – U-ACHIEVE (induction), U-ACCOMPLISH and U-ACHIEVE (maintenance) – evaluating upadacitinib
Yahoo Web Search
Top News Videos for Psoriatic Arthritis
03:11Lance Bass opens up about living with psoriatic arthritis
ABC News Videos via Yahoo News
· 1 week agoTrending Now
